Propiedad y actividad de insiders de Kiniksa Pharmaceuticals International, plc (KNSA): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $76.27 |
| Capitalización | $5.8B |
| Bolsa | NASDAQ |
| País | GB |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $56.0M | $45.6M | $307.3M | $46.9M | $114.0M | $122.5M | $122.7M | $108.0M | $183.6M | $165.6M |
| Inversiones a Corto | 0 | 0 | 0 | $186.5M | $209.4M | $59.7M | $67.9M | $98.4M | $60.0M | $248.5M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | $4.0M | $20.3M | $21.3M | $41.7M | $15.6M |
| Inventario | 0 | 0 | 0 | 0 | 0 | $3.7M | $21.6M | $31.1M | $26.4M | $54.9M |
| Activos Corrientes | $56.3M | $47.1M | $313.8M | $241.6M | $333.2M | $196.4M | $243.1M | $276.3M | $331.8M | $527.2M |
| Inmovilizado Material | $84000 | $125000 | $6.4M | $8.3M | $10.6M | $8.4M | $7.0M | $12.7M | $11.0M | $11.8M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | $19.2M | $18.2M | $17.2M | $16.2M | $15.2M |
| Activos Totales | $56.5M | $47.5M | $322.0M | $254.5M | $349.5M | $232.8M | $459.7M | $526.3M | $580.6M | $763.6M |
| Cuentas por Pagar | $212000 | $1.2M | $10.9M | $5.7M | $503000 | $1.9M | $7.9M | $8.2M | $2.0M | $2.0M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $3.0M |
| Pasivos Corrientes | $2.3M | $17.4M | $42.6M | $27.8M | $31.8M | $44.8M | $47.1M | $63.7M | $100.6M | $139.2M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $82.2M | $137.2M | $42.7M | $29.1M | $37.5M | $47.8M | $63.5M | $87.5M | $142.1M | $196.0M |
| Reservas | -$26.1M | -$91.0M | -$194.2M | -$356.1M | -$517.5M | -$675.4M | -$492.0M | -$477.9M | -$521.1M | -$462.1M |
| Patrimonio Neto | -$25.7M | -$89.7M | -$194.2M | $225.4M | $311.9M | $185.0M | $396.1M | $438.8M | $438.4M | $567.6M |
| Deuda Total | 0 | 0 | 0 | $2.7M | $7.0M | $6.0M | $5.9M | $12.3M | $9.9M | $9.5M |
| Deuda Neta | -$56.0M | -$45.6M | -$307.3M | -$230.7M | -$316.5M | -$176.2M | -$184.7M | -$194.1M | -$233.8M | -$404.6M |
| Capital Circulante | $54.0M | $29.7M | $271.2M | $213.8M | $301.4M | $151.6M | $196.0M | $212.6M | $231.2M | $388.0M |
Salud financiera
| Deuda / Patrimonio | 0.01 |
| Ratio corriente | 3.90 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 10.35 |
Rentabilidad
| Rentabilidad sobre capital | 13.65% |
| Rentabilidad sobre capital invertido | 9.71% |
| Rentabilidad sobre activos | 9.00% |
| Margen bruto | 54.49% |
| Margen operativo | 11.92% |
| Margen neto | 9.59% |
Empresas relacionadas: ADPT · APLS · CDTX · CPRX · FOLD · IDYA · MLYS
Explorar sector: Healthcare · Medical - Pharmaceuticals
Más secciones de KNSA: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones